Celltrion has partnered with Japan’s largest bio cluster, the Kobe Biomedical Innovation Cluster (KBIC), to support the global expansion of promising biotech startups. The collaboration was announced at an offline briefing held on the 8th at the Tokyo LINK‑J (Life Science Innovation Network Japan) headquarters.
The initiative, named the “2026 KBIC‑Celltrion Global Scale‑up Program,” marks the first time a Korean company co‑plans and operates a program with a Japanese bio cluster, representing a historic Korea‑Japan public‑private partnership aimed at accelerating biotech innovation and market entry.
Tagesnachrichten20. Sept. 2026•1 Min. Lesezeit
Celltrion & Kobe Cluster Launch 2026 Global Scale‑up Program
Celltrion announced a partnership with Japan’s Kobe Biomedical Innovation Cluster, launching the 2026 KBIC‑Celltrion Global Scale‑up Program to help promising biotech startups expand globally.
Zusammengestellt vom PharmaCountry-Team · Quelle: KPA News
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen